menu search

Newmont: an industry-leading dividend yield at a reasonable price

Newmont released its Q3 results last month, reporting higher operating costs due to higher gold prices and inflationary pressures. This has translated...

November 28, 2021, 9:17 pm

Intellia: a step closer to a life-changing cure

Q3 earnings are out: Intellia has a strong cash position. NTLA-2001 shows good results in dose escalation ...

November 21, 2021, 9:05 am

Intellia: a step closer to a life-changing cure

Q3 earnings are out: Intellia has a strong cash position. NTLA-2001 shows good results in dose escalation ...

November 21, 2021, 9:05 am

Intellia: a step closer to a life-changing cure

Q3 earnings are out: Intellia has a strong cash position. NTLA-2001 shows good results in dose escalation ...

November 21, 2021, 9:05 am

Volkswagen ceo speaks to workers to defuse open conflict over reform

Volkswagen CEO Herbert Diess faced off workers at the carmaker's Wolfsburg plant on Thursday, seeking to avert the further ...

November 4, 2021, 6:38 am

Volkswagen ceo speaks to workers to defuse open conflict over reform

Volkswagen CEO Herbert Diess faced off workers at the carmaker's Wolfsburg plant on Thursday, seeking to avert the further ...

November 4, 2021, 6:38 am

Volkswagen ceo speaks to workers to defuse open conflict over reform

Volkswagen CEO Herbert Diess faced off workers at the carmaker's Wolfsburg plant on Thursday, seeking to avert the further ...

November 4, 2021, 6:38 am

Oshkosh shares slide 5.4% premarket after truck-maker cuts q4 guidance citing supply chain snags

Oshkosh Corp. shares OSK, +1.16% slid 5.4% in premarket trade Friday, after the maker of trucks and emergency vehicles warned that supply-chain and lo...

October 8, 2021, 7:03 am

Oshkosh shares slide 5.4% premarket after truck-maker cuts q4 guidance citing supply chain snags

Oshkosh Corp. shares OSK, +1.16% slid 5.4% in premarket trade Friday, after the maker of trucks and emergency vehicles warned that supply-chain and lo...

October 8, 2021, 7:03 am

Oshkosh shares slide 5.4% premarket after truck-maker cuts q4 guidance citing supply chain snags

Oshkosh Corp. shares OSK, +1.16% slid 5.4% in premarket trade Friday, after the maker of trucks and emergency vehicles warned that supply-chain and lo...

October 8, 2021, 7:03 am

Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial

Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-...

October 7, 2021, 3:29 pm

Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial

Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-...

October 7, 2021, 3:29 pm

Bicycle therapeutics stock falls after interim data of toxin conjugates in ovarian cancer trial

Bicycle Therapeutics plc (NASDAQ: BCYC) has reported interim Phase I trial results for BT5528 and preliminary findings from the ongoing dose-...

October 7, 2021, 3:29 pm

7 defense stocks to watch as taiwan tensions heighten

Although tensions between China and Taiwan are nothing new, the latest wave of escalations put a new focus on defense stocks. The post 7 Defense Stock...

October 7, 2021, 10:46 am

7 defense stocks to watch as taiwan tensions heighten

Although tensions between China and Taiwan are nothing new, the latest wave of escalations put a new focus on defense stocks. The post 7 Defense Stock...

October 7, 2021, 10:46 am

7 defense stocks to watch as taiwan tensions heighten

Although tensions between China and Taiwan are nothing new, the latest wave of escalations put a new focus on defense stocks. The post 7 Defense Stock...

October 7, 2021, 10:46 am

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm

Pharmaxis cleared to progress to phase 2 bone marrow cancer trial

Pharmaxis Ltd (ASX:PXS), a clinical-stage drug development company, has received positive results from data analysis of a phase 1c clinical trial (MF...

October 4, 2021, 11:34 pm


Search within

Pages Search Results: